Neurone Studio S.A. (WSE:NRS)

Neurone Studio Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Cash & Equivalents	-	0.02	0
Cash & Short-Term Investments	-	0.02	0
Cash Growth	-	-	-
Accounts Receivable	0.07	0	0.05
Other Receivables	-	0.06	0.05
Total Trade Receivables	0.07	0.06	0.09
Inventory	-	0.12	0.12
Total Current Assets	0.07	0.2	0.21
Other Intangible Assets	0	0.01	0
Total Assets	0.07	0.21	0.21
Accounts Payable	-	0.03	0.03
Accrued Expenses	0.01	0.02	0
Short-Term Debt	-	0	0.38
Other Current Liabilities	-	0.04	0
Total Current Liabilities	0.01	0.09	0.41
Other Long-Term Liabilities	0.18	0.12	0
Total Long-Term Liabilities	0.18	0.12	0
Total Liabilities	0.18	0.21	0.41
Common Stock	0.28	0.28	0.22
Additional Paid-in Capital	4.56	4.56	4.05
Retained Earnings	-4.95	-4.83	-4.46
Shareholders' Equity	-0.11	0	-0.19
Total Liabilities & Equity	0.07	0.21	0.21

Data Source: Fiscal.ai Last updated: May 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error